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Summary Photodynamic therapy (PDT) depends on the interaction of light with an administered photosen-
sitiser to produce a local cytotoxic effect. The most widely used photosensitiser is haematoporphyrin derivative
(HpD), but newer photosensitisers such as aluminium sulphonated phthalocyanine (AlSPc) are promising.
HpD and AlSPc have been compared as photosensitisers for colonic PDT in the rat. Quantitative analysis
showed that following injection of a standard photosensitiser dose, AlSPc produced more damage than HpD
with increasing energy (fluence). Alteration of the injected dose of photosensitiser did not produce a clear
difference. There was a loss of reciprocity for photosensitiser/light combinations at low injected dose
(0.5 mg kg-'), both HpD and AlSPc producing no damage. Similarly at high photosensitiser dosage (25 mg
kg-') there was no quantitative difference between AlSPc and HpD. Photosensitiser photodegradation at low
photosensitiser doses, and light attenuation by high tissue concentrations of AlSPc account for these findings.
PDT with either agent produced the same histological damage and full thickness necrosis produced no
mechanical weakening of the colon measured by the bursting pressure. The submucosal collagen was preserved
and healing was by regeneration.
The ideal photosensitiser for photodynamic therapy (PDT)
has yet to be identified. Two groups of agents that are being
extensively investigated are the phthalocyanines and the por-
phyrins. There are distinct chemical and photochemical dif-
ferences between these agents. Haematoporphyrin derivative
(HpD) is at present the most widely studied photosensitiser,
and it is against this compound that other photosensitisers
have to be compared. The major theoretical objections to
HpD are that it is a variable mixture of porphyrins with only
a small absorption peak in the red at 630 nm (Berenbaum et
al., 1982). We have compared this agent with aluminium
sulphonated phthalocyanine (AlSPc). This was not a pure
compound, but a mixture with varying degrees of sulphona-
tion, although it has a large absorption peak at 675 nm
(Bown et al., 1986). For clinical PDT it is generally necessary
to use a wavelength at the red end of the spectrum in order
to get adequate tissue penetration of light. There are a few
studies that directly compare the effectiveness of different
photosensitisers (Berenbaum et al., 1986), but no quantitative
comparison of prophyrins and phthalocyanines.
These experiments compared the efficacy of both photosen-
sitisers for colonic PDT for a range of light fluences and
photosensitiser doses. We have previously reported in detail
the effect of PDT on the normal rodent colon with AlSPc
(Barr et al., 1987a,b). These studies demonstrated that full
thickness necrosis produced by photodynamic therapy fol-
lowing phthalocyanine photosensitisation did not reduce the
mechanical strength of the colonic wall and healing was
predominantly by regeneration. These findings offer very
important biological advantages for the endoscopic treatment
of gastrointestinal cancers with photodynamic therapy. Some
small tumours may be destroyed without risking perforation
and there is less chance of producing a stricture. It is impor-
tant to determine whether these photodynamic effects are
independent of the nature of the photosensitiser.
Materials and methods
Photosensitisers
Aluminium sulphonated phthalocyanine was obtained from
Ciba-Geigy, and was dissolved in normal saline prior to
injection. It contained an average of three sulphonic groups
per molecule (Darwent et al., 1982). The solution was kept in
the dark but no other special precautions were taken.
Haematoporphyrin derivative was supplied by Paisley Bio-
chemicals Ltd (Glasgow) and synthesised to yield approxi-
mately 60% of photosensitising esters. This solution was kept
in the dark below OC.
Photodynamic therapy
Male Wistar (180-250 g) rats were used to compare HpD
and AlSPc for colonic photodynamic therapy. All procedures
were performed under general anaesthesia from intramus-
cular Hypnorm (fentanyl and fluanisone). The animals were
injected intravenously (via the tail vein) with HpD or AlSPc
under exactly the same conditions. A completely fresh sample
of HpD was used each time. It is clear that prolonged
storage of HpD and in particular refreezing of the sample
can have quite profound effects on the photochemistry
(Dougherty, 1987).
One hour following intravenous injection, a laparotomy
was performed and the mobile portion of the colon was
exteriorised onto the anterior abdominal wall. Initial
experiments were also performed at 3, 48 and 168h after
photosensitisation with both photosensitisers. No difference
was apparent in the nature or quantitative pattern of the
damage. The largest lesions occured when phototherapy was
1 h after photosensitisation. Overall the largest areas of
damage after photosensitisation with AlSPc occur following
the profound vascular effects produced when phototherapy
immediately follows photosensitisation (Barr et al., 1987a).
However, this effect was not so evident and less predictable
following HpD photosensitisation (Bown et al., 1986). Thus
all quantitative studies were performed 1 h after photosen-
sitisation.
A continuous-wave argon pumped dye laser (Cooper
Laseronics, CA, USA) with the output coupled to a 0.2 mm
quartz laser fibre was set to deliver 100 mW. The laser was
tuned to 630 nm for treatment of animals photosensitised
with HpD, and 675 nm for those treated with AlSPc. A
portion of colon on the right side had any faecal matter
gently milked away. The laser fibre was inserted into the
lumen of the bowel by puncturing the colonic wall. It was
threaded along the colon to a convenient point and held in a
clamp just touching the colonic wall. The laser was switched
on for the time planned for the exposure. The colon was kept
moist with occasional irrigation with 0.9% saline. The laser
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fibre was removed and the entry site marked with a silk
suture. The distance from this point to the treated area was
measured with a micrometer. Control experiments were per-
formed on unsensitised animals at both wavelengths with this
laser power. Following exposure at 50 and 200J (1OOmW
for 500 and 2,000 s), small areas of thermal damage asso-
ciated with the tip of the laser fibre could be identified 72 h
after treatment. There was no difference between the radius
of necrosis associated with thermal damage at the different
wavelengths. Those control data are shown in the figures. At
lower energies thermal damage could only occasionally be
identified at histological examination and was never seen
macroscopically. Animals were treated under the following
circumstances.
Variable delivered energy
The animals were sensitised with 5 mg kg-' AlSPc or HpD
and treated 1 h after injection. The laser was set to deliver
100 mW for between 10 and 2,000 s altering the delivered
energy from 1 to 200 J. The animals were allowed to recover
and killed 72 h after treatment, and the colon was removed.
The PDT lesions were sharply demarcated oval areas. The
radius of necrosis was measured under the operating micro-
scope (Wild M650), by measuring the two major radii at
right angles to each other and taking the mean (Barr et al.,
1987a). All lesions were fixed in 10% formalin and prepared
for histological examination.
Variable photosensitiser dose
Animals were sensitised with 0.5, 1, 2.5, 5, 10 and 25 mgkg-'
of HpD or AlSPc. They were all treated 1 h after intravenous
injection. The concentration of the photosensitiser was
adjusted so that the volume of fluid injected was 0.75-1 ml.
Phototherapy was delivered at the appropriate wavelength.
The laser was set to deliver 100 mW for 500 s (50 J). The
animals were allowed to recover and then killed 72 h after
treatment, at which time there was a sharply demarcated
lesion that could be measured as above.
Temperature measurement during PDT
Apart from local thermal damage associated with the tip of
the laser fibre, any general rise in tissue temperature associ-
ated with laser irradiation may cause hyperthermic tissue
destruction. It was important to know that there was no
temperature rise in the colon apart from that at the small
area of thermal injury associated with the laser fibre tip
already identified. The temperature in the colonic wall was
measured using an array of six copper/constantan micro-
thermocouples inserted under the serosa of the colon, and
connected to a seven-channel temperature logger. Using the
operating microscope a small intravenous cannula was insert-
ed under the serosa, the microthermocouple array was
inserted through this and the cannula withdrawn. The laser
fibre was placed as for PDT on the bowel mucosa as near as
possible to the thermocouples. The temperature was measured
at 630 nm and 675 nm with the laser set to deliver 100 mW
for 1,000 s. The animal's core temperature was measured by
a separate needle thermocouple inserted into the animal's
thigh muscle.
Measurement ofthe mechanical strength ofthe colon after
PDT
Photodynamic therapy of normal colon with AlSPc has been
shown not to weaken the colonic wall. The method of
gaseous distension to measure the bursting pressure has been
previously described (Barr et al., 1987a). Normal colon
treated 1 h after photosensitisation with HpD or AlSPc was
removed at 72 and 96 h (the time when histological full
thickness necrosis is present) and the bursting pressure
measured. The injected dose of photosensitiser was 5 mg kg-'
and the laser was set to deliver 100 mW for 2,000s (200 J).
The method of treatment was as described above.
Histology
Animals were injected with 5 mg kg-' HpD and AlSPc and
treated 1 or 48 h after with 100 mW for 500 s of light as
described above. Animals were killed from 3 h to 3 weeks
after treatment. The area of treatment was identified and
fixed in 10% formalin and prepared for histological examina-
tion. They were stained with haematoxylin and eosin. In
some sections an elastic-Van Gieson stain was used to dem-
onstrate the submucosal collagen layer, which has been
shown to be preserved following PDT with AlSPc (Barr et
al., 1987b).
Results
Variable light energy
Figure 1 shows the results obtained by altering the delivered
energy, for a standard injected dose of AlSPc and HpD. It is
clear that HpD produces less damage than AlSPc and there
are different energy thresholds to produce necrosis. Follow-
ing photosensitisation with 5mgkg-' HpD, 5J of energy
failed to produce a lesion, and the energy threshold was
between 5 and 10 J. In contrast the energy threshold to
produce necrosis with ALSPc was between 1 and 5 J at this
injected dose.
Variable photosensitiser dose
Figure 2 shows the results of altering the administered dose
of AlSPc and HpD. The radium of necrosis produced follow-
ing photosensitisation with 0.5 mg kg' AlSPc and 0.5 and
I mg kg-' HpD was no greater than control. It is apparent
that at low dose (0.5 mg kg-') and at high dose (25 mg kg-')
there was no difference between the amount of necrosis
produced by the different photosensitisers. However, at 1,
2.5, 5 and 1Omg kg' HpD produces smaller lesions than
AlSPc.
Temperature measurement
The maximum temperature measured from any thermocouple
at 630 nm and 675 nm is shown in Figure 3. The temperature
in the colonic wall remained at 31-34°C during irradiation.
Since the colon was kept moist and exteriorised the temper-
ature never reached the animal's core temperature and never
reached a hyperthermic temperature (Kinsey et al., 1983).
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Figure 1 Mean radius of PDT necrosis in normal colon as a
function of the applied energy for a laser power of 100 mW, 1 h
after injection of 5 mgkg-' of the photosensitiser. Each point
represents the mean with the standard error of the mean from at
least three separate animals. AlSPc (open square, continuous
line), HpD (open circle, dotted line). Control lesion produced by
100 mW of laser light for 500 and 2,000 s (50 and 200 J) in
unphotosensitised animals treated at 630 and 675 nm (filled trian-
gle).
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Figure 2 Mean radius of PDT necrosis in normal colon as a
function of the dose of administered photosensitiser. PDT per-
formed 3 h after intravenous injection of the photosensitiser; light
dose: 100 mW for 500 s (50 J). Each point represents the mean
with standard error of the mean from at least three separate
animals (five animals treated following photosensitisation with
25 mg kg-'). AISPc (open square, continuous line), HpD (open
circle, broken line). Control (filled triangle): colon treated without
photosensitisation with lOOmW for 500s (50J).
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Figure 4 Mean bursting pressure of colon following PDT with
HpD and AISPc. Phototherapy performed 1 h after injection of
5mgkg-' of photosensitiser, laser set to deliver lOOmW for
2,000s (200J). Each point represents the mean measurements
from at least three animals (±s.e.m.). AlSPc (open square), HpD
(open circle). The continuous line is the mean control bursting
pressure from 11 separate animals.
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Figure 3 Temperature recorded in the subserosal area of normal
colon during PDT. Phototherapy performed 1 h after photosen-
sitisation with HpD or AlSPc (5 mgkg-'), with laser tuned to
630 nm (open triangle) or 675 nm (open circle) and a power of
100 mW. The animal's core temperature (filled square) was
measured with a needle thermocouple in the thigh muscle. The
temperatures recorded are the maximum obtained from any of
the thermocouples (three recordings from separate animals)'
Mechanical strength oftreated colon
Figure 4 shows the bursting pressure of the colon after PDT
with HpD and AISPc photosensitisation. There is no reduc-
tion in the bursting pressure despite full thickness necrosis.
Bursting did not occur through the PDT lesion.
Histology
Histological examination of the lesions produced by photo-
dynamic therapy with HpD as the photosensitiser showed
that there was no difference between the progression of
damage and healing compared with AISPc. The initial re-
sponse of the tissue was evident in the blood vessels, with
dilatation and haemorrhage in the submucosal vessels occurr-
ing within 3 h of light exposure. Figures 5 and 6 show colon
3 h after PDT with HpD and AlSPc respectively. The tissue
appearances are exactly the same. All subsequent histological
Figure 5 Section of normal colon 3 h after PDT with 100 mW
for 500 s (50 J). Photosensitisation with 5 mg kg-' HpD, I h
before light exposure. This section shows haemorrhage and
oedema in the submucosal layer (H&E x 26).
sections showed no difference between the photosensitisers
evident on microscopy and were the same as the findings
presented previously (Barr et al., 1987a). Full thickness ne-
crosis was evident at 48-96 h. Two weeks after phototherapy
the colon had healed by regeneration.
Figure 7 shows that the submucosal collagen (stained with
elastic-Van Gieson) was undamaged when HpD was the
photosensitiser as was found with AISPc (Barr et al., 1987a).
Discussion
It was demonstrated by Bown et al. (1986) that photo-
dynamic therapy using light energies from 1 to 200 J follow-
ing photosensitisation with HpD produced less damage to
the normal rat liver than following photosensitisation with
AlSPc, after intravenous injection of a standard dose of
5 mgkg-. Our findings agree with this for a fixed dose of
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Figure 6 Section of normal colon 3 h after PDT with 100mW
for 500 s (50 J). Photosensitisation with 5 mg kg-' AlSPc, 1 h
before light exposure. The findings are no different from those
following photosensitisation with HpD (H&E x 26).
Figure 7 Section to show submucosal colonic collagen 72 h after
phototherapy (100 mW for 2,000 s, 200 J), photosensitisation
with 5 mg kg-' HpD). A damaged blood vessel is seen in the
centre with necrotic tissue around it. The collagen fibrils are seen
to be intact and remain present after PDT (elastic-Van Geison,
x 60).
photosensitiser (5 mg kg-') and a variable light dose. There is
no report of a comparative study examining the two photo-
sensitisers at a range of administered doses. It is clear that at
2.5, 5 and 1Omg kg-' the amount of damage is greater for
AlSPc than HpD on a weight for weight basis. However,
following injection of 0.5 mg kg-' AlSPc or HpD, there is no
difference between the photosensitisers, since no photo-
dynamic damage occurs (no different from control unsen-
sitised animals). No photodynamic damage is evident also
when the injected dose of HpD is 1mg kg-'. After injection
of 25 mg kg-', there is also no difference between the
photosensitisers; the amount of damage produced is exactly
the same. The explanation is complex as there are two
separate processes occurring, one at low dose and one at high
dose.
It is clear that for AlSPc, at an injected dose of 25 mg
kg-', the amount of damage is less than expected although,
in view of the small number of animals used, some caution is
required. In order to examine this effect, it is helpful to
consider the 'photodynamic dose' (Wilson et al., 1986). This
can be defined as:
Photodynamic dose=
tissue concentration of photosensitiser x fluence
The tissue concentration of AlSPc at a given time after
injection has an approximately linear relationship with the
injected dose of photosensitiser (Tralau, 1988). If similar
relationships are assumed for HpD, a more simple equation
can be used.
Photodynamic dose = injected photosensitiser dose x energy
Using this approximation to construct Table I we have cal-
culated the photodynamic dose to allow simple comparison
of the different photosensitisers. At a photodynamic dose
1,000, the radius of necrosis with AlSPc (8.3 mm) is greater
than that for HpD (5.8 mm). Consider the data in Table I to
give a greater photodynamic dose of 1,250. Despite this
increase, the amount of necrosis following AlSPc photosen-
sitiation has fallen to 6.3 mm, whereas with HpD the amount
of necrosis has increased to 6.3 mm. It is apparent, that on
an increase in the photodynamic dose from 1,000 to 1,250,
the amount of necrosis rises as expected following photosen-
sitisation with HpD, but falls with AlSPc.
At high photosensitiser dose with a highly absorbing
photosensitiser such as AlSPc the penetration of light in the
tissues may be significantly reduced. Bown et al. (1986)
noticed that for a fixed light dose the depth of necrosis in the
liver first increased with increasing concentration of AlSPc
then decreased. The fall off in effect was presumed to be due
to absorption of light by large amounts of AlSPc in the liver
reducing the optical penetration depth. They noted that at
high doses the liver appeared almost black. There is also
further evidence for this effect. Wilson et al. (1986) have
performed an important series ofexperiments and theoretical
analysis to discover the effect of photosensitiser concen-
tration on the tissue penetration of red light with AISPC.
They state that the absorption coefficient of tissue with the
addition of a photosensitiser can be given by:
Tissue absorption coefficient = inherent tissue absorption coefficient
+ absorption coefficient of photosensitiser
The absorption coefficient of the photosensitiser can be given
by:
Absorption coefficient of photosensitiser=
concentration of the photosensitiser x
specific absorbence of the photosensitiser at the wavelength used
Although there are no comparative data on HpD and
AlSPc uptake in rat colon, studies of Photofrin II uptake in
mouse colon have been performed (Pantelides et al., 1989).
When compared with AlSPc concentrations in rodent colon
(Barr et al., 1987a), there are similar levels of uptake.
Therefore, there is unlikely to be a major difference due to
the concentration in the colon. However, the extinction
coefficient of HpD at 630nm is 7 x 10-4mm' (jagg-')-I
and is 22 times lower than that of AlSPc at 675 nm
(0.015 mm-' (f.g g-')-') (Wilson et al., 1986). Thus the tissue
absorption coefficient of colon will be increased more when
AlSPc rather than HpD is used as the photosensitiser. There-
fore at high photosensitiser dose the light penetration could
be reduced to such an extent that the energy threshold is not
reached in the distal parts of the tissue. Therefore the
amount of necrosis is lower than would be expected.
From Table I it is clear that at low dose there is a loss of
reciprocity between the photosensitiser dose and the delivered
energy. Following AlSPc photosensitisation a photodynamic
dose of 25 produces no necrosis when the injected dose is
0.5 mg kg-' (energy 50 J), but 2 mm of necrosis if 5 mg kg-'
(energy 5 J) is used. A photodynamic dose of 50 following
photosensitisation with an injected dose of 1 mg kg-i HpD
(energy 50 J) caused no damage, yet 2 mm of necrosis fol-
lowed photosensitisation with 5 mg kg-' (energy 10 J). The
simple definition of photodyamic dose given above breaks
down at low photosensitiser doses. It has been shown that a
threshold photosensitiser dose is required for necrosis to
occur, whatever amount of energy is delivered (Barr et al.,
1989). It has also been demonstrated that photodegradation
occurs with both HpD (Potter et al., 1987) and AlSPc (Barr
et al., 1988). At low dose the occurrence of photosensitiser734 H. BARR et al.
Table I Radium of necrosis in relation to the photodynamic dose for AlSPc and
HpD
Drug dose Energy Photodynamic
(mgkg-) (J) dose Radium ofnecrosis (mm)
AlSPc 0.5 50 25 0 (0.4) (no difference from
control: Figure 2)
5 5 25 2±0.2 (Figure 1)
5 200 1000 8.3±0.4 (Figure 1)
25 50 1250 6.3±0.9 (Figure 2)
HpD 1 50 50 0 (0.6) (no difference from
control: Figure 2)
5 10 50 1.9±0.3 (Figure 1)
5 200 1000 5.8±0.4 (Figure 1)
25 50 1250 6.3±0.6 (Figure 2)
photodegradation becomes evident. The photosensitisers are
photodegraded such that a threshold photodynamic dose is
not reached and no photodynamic damage is produced. The
threshold photodynamic dose is reached following photosen-
sitisation with AISPc at an injected dose of 1 mg kg-', and at
an injected dose of 2.5 mgkg-' with HpD. It is not surpris-
ing that different threshold doses should apply for AlSPc and
HpD since these compounds with widely divergent absorp-
tion coefficients are unlikely to photodegrade at similar rates.
There is no difference evident at histological examination
for photodynamic damaged produced by AISPc or HpD.
Lesions produced using HpD as the photosensitiser appear to
be generated and to heal in the same way as those produced
using AlSPc. Other studies (Selman et al., 1986) have shown
that both HpD and AlSPc have a similar effect on tumour
microcirculation, both appearing to share a final common
pathway for the production of tissue damage and vascular
occlusion. Although there is conflicting evidence as to wheth-
er the mechanism of damage of different photosensitisers is
the same and mediated through singlet oxygen (Rosenthal et
al., 1986), it is clear from this study that the end biological
effect is the same. In particular the important biological
advantage of PDT of maintaining the mechanical strength of
the colon despite producing full thickness necrosis is not
dependent on the photosensitiser used. The preservation of
submucosal colonic collagen occurs following both HpD and
AlSPc photosensitisation and is probably a general feature of
photodynamic damage.
AlSPc was found by Chan et al. (1986) to be less toxic to
cells in culture in both darkness and following exposure to
room light (fluorescent tubes with little red emission). These
re?ults suggested that the undesirable effects of cutaneous
photosensitisation that have been reported to be a significant
problem with HpD (Carruth & McKenzie, 1985) may be less
marked with ALSPc. Recently a direct comparison of the
skin photosensitising potential of porphyrins and AlSPc has
been performed using Skh 1 hairless albino mice irradiated
using a WG320 filtered 2 kW xenon arc lamp (Tralau et al.,
1989). It was apparent that mice photosensitised with AISPc
had less severe, shorter lived reactions. Porphyrins also pro-
duced skin photosensitivity lasting 1 month, whereas AISPc
photosensitised animals had lost their skin photosensitivity 2
weeks after injection.
We have previously demonstrated that the selective reten-
tion of AISPc in tumours appears to be predominantly a
property of the tumour rather than the photosensitiser. Cer-
tainly the uptake of HpD and AlSPc is very similar in similar
tumours (Tralau et al., 1987). AISPc produces more damage
at standard dose of 5 mgkg-' over a range of energies, due
in most part to the greater absorption at a longer wavelength
in the red. However, the high absorption is a disadvantage
and reduces tissue penetration of light at high administered
drug dosage. It is important to note that the biological effect
of different photosensitisers is similar, with tissue damage
unlikely to cause perforation and healing occurring by
regeneration.
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